RAKOVINA THERAPEUTICS INCRAKOVINA THERAPEUTICS INCRAKOVINA THERAPEUTICS INC

RAKOVINA THERAPEUTICS INC

No trades
See on Supercharts
Market capitalization
‪8.04 M‬CAD
−0.045CAD
‪−2.61 M‬CAD
0.00CAD
‪34.33 M‬
Beta (1Y)
−1.54

About RAKOVINA THERAPEUTICS INC


Sector
Headquarters
Vancouver
Founded
2019
FIGI
BBG00RN62JS7
Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RKV is 0.160 CAD — it has increased by 6.67% in the past 24 hours. Watch RAKOVINA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange RAKOVINA THERAPEUTICS INC stocks are traded under the ticker RKV.
RKV stock has risen by 14.29% compared to the previous week, the month change is a 146.15% rise, over the last year RAKOVINA THERAPEUTICS INC has showed a 113.33% increase.
RKV reached its all-time high on Apr 5, 2021 with the price of 0.395 CAD, and its all-time low was 0.005 CAD and was reached on Feb 26, 2024. View more price dynamics on RKV chart.
See other stocks reaching their highest and lowest prices.
RKV stock is 6.67% volatile and has beta coefficient of −1.54. Track RAKOVINA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is RAKOVINA THERAPEUTICS INC there?
Today RAKOVINA THERAPEUTICS INC has the market capitalization of ‪8.58 M‬, it has decreased by −10.34% over the last week.
Yes, you can track RAKOVINA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
RKV net income for the last quarter is ‪−1.02 M‬ CAD, while the quarter before that showed ‪−820.58 K‬ CAD of net income which accounts for −23.77% change. Track more RAKOVINA THERAPEUTICS INC financial stats to get the full picture.
No, RKV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RKV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAKOVINA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAKOVINA THERAPEUTICS INC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAKOVINA THERAPEUTICS INC stock shows the strong buy signal. See more of RAKOVINA THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.